"EU Drug Regulator's Review of Lilly's Mounjaro Multi-Dose Pen"
The European Union's healthcare regulator will review Eli Lilly's Mounjaro drug, used for treating type 2 diabetes and obesity, when prefilled in a multi-dose injection pen. The U.S. drugmaker has initially made starter doses available in Germany and Poland packaged in vials, but the "Kwikpen" multi-dose injection device for Mounjaro is now being considered as a new route of administration by an expert panel of the European Medicines Agency. Lilly has indicated that European approval of the pen injector could come by the middle of the year.